The mechanism of improved sodium homeostasis of low‐dose losartan in preascitic cirrhosis
Florence Wong, Peter Liu, Laurence Blendis – 30 December 2003 – Renal sodium retention on standing is one aspect of the abnormal renal sodium handling in preascitic, well‐compensated patients with cirrhosis. Recently, it has been shown that low doses (7.5 mg) of the angiotensin II (Ang II) receptor antagonist, losartan, can reverse renal sodium retention on high, 200‐mmol sodium/d diet in these patients and restore them to sodium balance.